Impact of biobanks on research outcomes in rare diseases: a systematic review.

Main|Search|PHGKB


Last Posted: Nov 15, 2018

---

• Impact of biobanks on research outcomes in rare diseases: a systematic review.
  Garcia Monique et al. Orphanet journal of rare diseases 2018 Nov 13(1) 202
• New ACC/AHA Cholesterol Guideline Allows For More Personalized Care; New Treatment Options
  American College of Cardiology, November 10, 2018
• Patient and Provider Perspectives on a Decision Aid for Familial Hypercholesterolemia.
  Farwati Medhat et al. Journal of personalized medicine 2018 Nov 8(4)
• Whole Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized with Early-Onset Myocardial Infarction
  AV Khera et al, circulation, November 11, 2018
• Familial Hypercholesterolemia: Clinician and Patient Insights
  American College of Cardiology, October 2018
• Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease.
  Benito-Vicente Asier et al. International journal of molecular sciences 2018 Nov 19(11)
• The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results.
  Kullo Iftikhar J et al. Mayo Clinic proceedings 2018 Nov 93(11) 1600-1610
• A Global Call to Action on Familial Hypercholesterolemia 
  S Seim, The FH Foundation, October 321, 2018
• Healthcare Utilization and Patients' Perspectives After Receiving a Positive Genetic Test for Familial Hypercholesterolemia.
  Jones Laney K et al. Circulation. Genomic and precision medicine 2018 Aug 11(8) e002146
• Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia.
  Izar Maria Cristina de Oliveira et al. Arquivos brasileiros de cardiologia 2018 Oct 111(4) 585-586

more